Wall Street PR

Pacific Biosciences of California (NASDAQ:PACB) Sequencing Gets Added By Human Longevity Inc. For Deeper Insights Into Human Genetic Variation

Boston, MA 10/07/2014 (wallstreetpr) – According to reports, Pacific Biosciences of California (NASDAQ:PACB) announced lately that Human Longevity Inc. had added Single Molecule, Real-Time sequencing technology to get deeper insights into genetic variation.

Insights of the announcement:

SMRT technology of the firm has been added by Human Longevity Inc. in order to execute repertoire of DNA sequencing technologies that it uses for compiling the complete database record. Its database includes human microbiome, genotype and phenotype information. Although there are quite a few DNA sequencing technologies available, but Human Longevity Inc. has opted for one that PACB has, because of its unique features which cannot be found in others.

Management of HLI is very delighted to have entered into a deal with PACB. Recently J. Craig Venter, PhD, Co-founder, CEO and Chairman of HLI told reporters that Pacific Biosciences of California (NASDAQ:PACB)’s sequencing technology had everything that HLI was searching for years. According to him, its unique features and capability of covering human genome makes it superior to others. Long read sequencing fuels in confidence necessary for phasing haplotypes and calling structural variants. Both of them are very important in order to understand the human genome completely. One has to have the complete and most accurate genome of any individual in order to use it for clinical diagnostic purposes.

HLI has been trying to achieve this goal for years without any success, but now it can hope for the best through SMRT technology of PACB. A lot of publications and reports published recently have covered major important elements of SMRT technology, which has helped interested parties understanding it efficiently. As per the information shared by HLI, a long sequence reads provided by the Pacific Biosciences of California (NASDAQ:PACB) RS II are bonus for those who have used short reads from the high-throughput machine in the past. They enable human genome researchers to understand everything significantly well and use them accordingly.

Published by Brendan Byrne

While studying economics, Brendan found himself comfortably falling down the rabbit hole of restaurant work, ultimately opening a consulting business and working as a private wine buyer. On a whim, he moved to China, and in his first week following a triumphant pub quiz victory, he found himself bleeding on the floor based on his arrogance. The same man who put him there offered him a job lecturing for the University of Wales in various sister universities throughout the Middle Kingdom. While primarily lecturing in descriptive and comparative statistics, Brendan simultaneously earned an Msc in Banking and International Finance from the University of Wales-Bangor. He's presently doing something he hates, respecting French people. Well, two, his wife and her mother in the lovely town of Antigua, Guatemala. You may contact Brendan via his email (brendanbyrne@cablemanpro.com) or his Google+ page (https://plus.google.com/u/0/116608759701551457422).